
- Ashok Leyland sold 17,903 vehicles in February 2025.
- This represents a slight increase of 1.5% compared to the same month the previous year, when 17,632 vehicles were sold.
- Local sales, which formed a major portion of the company’s sales, stood at 15,879 units in February 2025.
- The local sales figures actually saw a decline of 4.5% compared to the previous year.
- Analyst ratings for Ashok Leyland include 36 buy ratings, 4 hold ratings, and 4 sell ratings.
“`
A look at Ashok Leyland Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
With a strong focus on dividend and growth, Ashok Leyland is positioned for long-term success in the commercial vehicle sector. Smartkarma Smart Scores indicate high marks in both dividend and growth potential, highlighting the company’s commitment to rewarding investors while also driving expansion. Additionally, a robust momentum score suggests positive market sentiment and potential for continued upward movement in stock value. Despite lower scores in value and resilience, the overall outlook for Ashok Leyland appears promising based on its strengths in dividend, growth, and momentum.
Ashok Leyland Limited, a leading manufacturer of commercial vehicles and related products, has earned top scores in dividend and growth potential according to Smartkarma Smart Scores. Operating in both domestic and international markets, the company offers a diverse range of medium and heavy-duty vehicles, industrial & marine engines, and spare parts. While facing some challenges in value and resilience aspects, Ashok Leyland‘s strong focus on dividends, growth, and momentum positions it well for sustained success in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars